Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 4/20 | 0.40 |
| ▸ | SIRT2 | Q8IXJ6 | 12/20 | 0.39 |
| ▸ | SIRT1 | Q96EB6 | 9/20 | 0.39 |
| ▸ | SIRT3 | Q9NTG7 | 6/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14477819 | 0.84 | SELP (0.37) | SELPSIRT2SIRT1SIRT3MEN1 | |
| SCHEMBL12197588 | 0.80 | SELP (0.43) | SELP | |
| SCHEMBL20019548 | 0.79 | SELP (0.51) | SELP | |
| SCHEMBL14477832 | 0.79 | SELP (0.43) | SELP | |
| SCHEMBL16772391 | 0.78 | SELP (0.39) | SELPSIRT2SIRT1SIRT3MEN1 | |
| SCHEMBL12202036 | 0.77 | SELP (0.45) | SELP | |
| SCHEMBL12202025 | 0.76 | PTPN1 (0.45) | SELP | |
| SCHEMBL12202028 | 0.76 | PTPN1 (0.45) | SELP | |
| SCHEMBL12202043 | 0.75 | SELP (0.52) | SELP | |
| SCHEMBL12202027 | 0.75 | PTPN1 (0.44) | SELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8853173-B2 | Synthetic glycolipid and use thereof | RIKEN (JP) | 2014-10-07 | — | — | US | disclosed |
| US-20130005669-A1 | NOVEL SYNTHETIC GLYCOLIPID AND USE THEREOF | RIKEN (JP) | 2013-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130005669-A1 | NOVEL SYNTHETIC GLYCOLIPID AND USE THEREOF | IFNG, IFNAR1, UGCG | SELP 1317/4885SIRT2 779/4885SIRT1 900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.